What Is in Delta-8? Molecule, Contaminants & Risks

Delta-8-THC is a naturally occurring cannabinoid found in cannabis, but the version sold in shops and online is almost never the natural molecule alone. It is typically synthesized from hemp-derived CBD through an acid-catalyzed chemical reaction, and the resulting product carries a mixture of the target compound, reaction byproducts, residual reagents, and sometimes terpene additives with their own risks. Understanding what is actually in a delta-8 product means looking at the intended molecule, the unintended chemistry riding alongside it, and what happens when you put all of it into your body.

The Molecule Itself

Delta-8-tetrahydrocannabinol is one of over a hundred cannabinoids produced by the cannabis plant. It was first isolated from marijuana grown in Maryland in 1966, though only in very small amounts.¹ Structurally, it is nearly identical to the more familiar delta-9-THC, the primary psychoactive compound in marijuana. The difference comes down to the position of a single chemical bond: in delta-9, a double bond sits between carbon atoms 9 and 10 on the molecule’s central ring, while in delta-8, that bond shifts one position over, sitting between carbons 8 and 9. That small repositioning changes how the molecule interacts with your brain’s cannabinoid receptors.

Delta-8 is a partial agonist of the CB1 receptor, the same receptor that delta-9-THC activates to produce a high. But delta-8 binds to CB1 with weaker affinity than delta-9, which accounts for much of the difference in potency between the two.² Once in your system, delta-8 is metabolized in the liver into active metabolites, including 11-hydroxy-delta-8-THC and 11-oxo-delta-8-THC, through the same enzyme system that processes delta-9.³ So delta-8 is not some inert hemp extract that happens to be relaxing. It is a psychoactive cannabinoid that gets you high, produces active metabolites, and acts on the same brain receptors as the THC in marijuana.

How Commercial Delta-8 Is Made

The cannabis plant produces delta-8-THC in trace concentrations, far too little to extract commercially. So virtually all delta-8 on the market is synthesized from CBD, which can be abundantly extracted from legal hemp. The conversion process is surprisingly accessible: CBD is dissolved in a solvent, an acid catalyst is added, and over a period of hours the CBD molecules rearrange into delta-8-THC.⁴ Step-by-step instructions for this conversion circulate freely on the internet, which has raised alarm among toxicologists and regulators.

The simplicity of the reaction is part of the problem. While converting CBD to delta-8 is not hard, doing it cleanly is. The acid-catalyzed process does not produce only delta-8-THC. It generates a range of side products depending on the specific acid used, the temperature, the reaction time, and how thoroughly the product is purified afterward. When performed in a well-equipped laboratory with proper analytical testing, many of these byproducts can be removed. When done on a kitchen counter or in an unregulated facility, the final product can be a chemical grab bag.

What Else Is in the Bottle

Researchers who have analyzed commercial delta-8 products have found a long list of compounds that should not be there, or at least have never been tested for human safety. One study isolated eleven distinct impurities from a single commercial delta-8 distillate, including compounds with names like delta-4,8-iso-tetrahydrocannabinol, 8-hydroxy-iso-tetrahydrocannabinol, and cannabicitran, along with olivetol and, critically, delta-9-THC itself.⁵ Most of these compounds have never been subjected to any human toxicological evaluation.⁶

That last point deserves emphasis. You are not just consuming delta-8 when you use these products. You are consuming a suite of novel cannabinoid-like compounds that may have their own psychoactive or toxic effects, and nobody has studied what those effects are. The delta-9-THC contamination is its own issue: someone buying delta-8 partly because they believe it is legal could be consuming a product that also contains the federally restricted compound, sometimes in amounts well above the 0.3% delta-9-THC threshold that defines legal hemp.

Labels That Do Not Match the Product

If the presence of unknown byproducts is one problem, the accuracy of product labeling is another. An analytical study of commercial delta-8 products found that the tested products contained impurities at concentrations far beyond what was declared on their certificates of analysis. In fact, none of the samples analyzed, with a single exception, had purity values consistent with what was printed on their labels.⁷ The certificates of analysis that accompany delta-8 products are often generated by third-party labs, but the lack of standardized testing requirements means these documents can range from reasonably accurate to wildly misleading.

For the consumer, this means you have limited ability to know what you are getting. The concentration of delta-8 may be lower than advertised. The concentration of byproducts may be higher than disclosed, or not disclosed at all. And unless the lab tested specifically for the unusual reaction byproducts of CBD-to-delta-8 conversion, those compounds could be present at substantial levels without ever showing up on a report.

How Delta-8 Compares to Delta-9 in Practice

Users frequently describe delta-8 as a milder, smoother version of conventional THC, and the limited clinical evidence supports that characterization, up to a point. In a large survey, about 80% of respondents rated the intensity of delta-8 effects as less than or equal to delta-9, and most also reported a shorter duration of effect.⁸ A controlled crossover trial with oral dosing found that 20 mg of delta-8 produced significantly fewer negative subjective effects, less cognitive impairment, and smaller heart rate increases than 20 mg of delta-9. However, at 40 mg of delta-8, the differences essentially vanished, and the two compounds produced comparable drug liking, suggesting similar potential for misuse.⁹

A separate trial using vaporized doses found a similar pattern: all delta-8 doses produced subjective drug effects distinct from placebo, and the higher vaporized doses of delta-8 were largely indistinguishable from delta-9 in how they made people feel.¹⁰ The takeaway is that delta-8 is genuinely less potent milligram-for-milligram, but people tend to compensate by using more, which erases the potency gap and brings the risk profile closer to that of regular THC. The idea that delta-8 is inherently “safer” because it is weaker does not hold up once you account for how people actually dose it.

The Terpene Problem in Vape Products

Many delta-8 vape cartridges contain added terpenes, the aromatic plant compounds responsible for flavor and scent. Terpenes are often marketed as natural and benign, but their behavior changes dramatically when heated in a vaporizer. Research on cannabis e-cigarettes has found that vaping THC with terpenes generates concerning degradation products including methacrolein, benzene, and methyl vinyl ketone, and that terpenes led to higher levels of gas-phase hazardous compounds than THC alone.¹¹

More recent work looking specifically at delta-8 and delta-10 vaping found that adding a commercial terpene oil mixture increased carbonyl emissions up to ninefold. Molecular analysis confirmed that these carbonyls originated primarily from the chemical oxidation of the terpenes themselves during vaping, not from the cannabinoids.¹² Carbonyls such as formaldehyde and acetaldehyde are known respiratory irritants and carcinogens. So the “natural flavoring” in a delta-8 cart may be the most chemically hazardous component in it, apart from whatever synthesis byproducts tagged along for the ride.

Poison Control Reports and Pediatric Cases

The rapid spread of delta-8 products has been tracked in real time through poison control data. Between January 2021 and December 2022, nearly 5,000 delta-8-THC exposures were reported to U.S. poison centers, with the rate per 100,000 people jumping roughly 80% from 2021 to 2022. About 70% of these cases came from the southern United States, where delta-8 availability was particularly widespread.¹³ A broader analysis covering delta-8, delta-10, and THC-O acetate found over 5,000 cases in the same period, with an even steeper rate of increase.¹⁴

Among the most alarming cases involve children. Delta-8 edibles are often sold as gummies in brightly colored packaging that closely resembles popular candy brands, making accidental ingestion by small children almost predictable. A two-year-old was airlifted to a hospital after eating what were thought to be CBD gummies but actually contained delta-8-THC. She arrived minimally responsive, with a Glasgow Coma Scale score of three (the lowest possible), and was intubated and admitted to the pediatric intensive care unit.¹⁵ In another case, two children who ate candy-like delta-8 products developed episodes of dangerously slow breathing and required about 45 hours of observation before discharge.¹⁶ Other pediatric cases have involved confusion, seizure-like activity, low blood pressure, and rapid heart rate.¹⁷

These cases are not just about the psychoactive effects of delta-8 in a small body. They also reflect the reality that the dose in a single gummy may be far higher than what even an adult intends to take in one sitting, and a child who eats several is getting a substantial psychoactive load with no tolerance and no understanding of what is happening. The candy-adjacent packaging remains legal in most states.

The Legal Gray Area That Made All of This Possible

Delta-8’s explosion into the consumer market traces directly to the 2018 Farm Bill, which removed hemp (defined as cannabis containing 0.3% or less delta-9-THC) from the federal Controlled Substances Act. The law was primarily intended to legalize industrial hemp and CBD products. But because it specifically defined the restricted compound as delta-9-THC rather than all forms of THC, an interpretation emerged that delta-8, delta-10, and other THC isomers synthesized from legal hemp could be sold nationwide, as long as the final product stayed under the 0.3% delta-9 limit.¹⁸

This legal ambiguity is a major driver of consumer interest. Survey data shows that the primary motivations for delta-8 use are its legal status and perceived therapeutic benefits.¹⁹ About half of delta-8 users in one survey reported using it to treat health conditions, most commonly anxiety, stress, depression, and chronic pain, and many said they substituted it for both conventional cannabis and pharmaceutical drugs.²⁰ For people in states without legal recreational marijuana, delta-8 often represents the only easily accessible legal THC product. The irony is that the lack of regulation means these consumers may be exposed to more chemical risk than someone buying tested, regulated delta-9 products in a state-licensed dispensary.

How Delta-8 Fits into the Broader Semi-Synthetic Cannabinoid Market

Delta-8 was the first hemp-derived THC isomer to reach mass-market scale, but it has since been joined by delta-10-THC, HHC (hexahydrocannabinol), THC-O acetate, and others. The manufacturing chain for several of these compounds passes through delta-8 as an intermediate. HHC, for instance, is commonly produced by first converting hemp CBD into a mixture of delta-8 and delta-9-THC, then hydrogenating that mixture to yield the saturated cannabinoid.²¹ Each additional chemical step introduces its own potential byproducts and impurities, meaning that the contamination concerns around delta-8 only multiply as the synthesis chain gets longer.

A common misconception is that these semi-synthetic cannabinoids are analogous to the fully synthetic cannabinoids (often called “Spice” or “K2”) that caused waves of hospitalizations in earlier years. They are not the same thing. Synthetic cannabinoids like JWH-018 are structurally unrelated to THC and act as full agonists at CB1 receptors, making them far more potent and dangerous. Delta-8 and its relatives are structural cousins of natural THC, act as partial agonists, and produce effects on a recognizable spectrum. The risk with delta-8 is not that the target molecule is inherently exotic or deadly. The risk is that the production and sale happen outside any quality framework, so you rarely know what else came along with it.

Drug Testing and Detection

Standard urine drug screens for THC do not distinguish between delta-8 and delta-9. Both compounds produce the same urinary metabolite, 11-nor-9-carboxy-THC, which is what immunoassay tests detect. If you use delta-8 products, you will test positive on a standard workplace drug test, and there is no simple way to prove the positive was caused by a legal hemp product rather than marijuana. More advanced blood testing methods using liquid chromatography with tandem mass spectrometry can separate and quantify the two THC isomers in blood, but this level of analysis is used in forensic and research settings, not in routine employment screening.

This creates a real practical problem for people who choose delta-8 because they believe it is a legal alternative. The legal status may protect you from criminal prosecution in your state, but it will not protect you from a failed drug test at work. Employers in most jurisdictions are under no obligation to distinguish between THC sources when enforcing their drug policies.

What Unregulated Production Actually Looks Like

It helps to understand the range of producers in this space. At one end, some delta-8 manufacturers operate with pharmaceutical-grade equipment, employ analytical chemists, and test extensively for byproducts. At the other end, the barrier to entry is so low that individuals are producing delta-8 in home labs using instructions from online forums, with no purification beyond crude distillation and no testing beyond the cheapest certificate of analysis they can purchase from a compliant lab. Both of these producers can sell their products in the same gas station or vape shop, and there is no labeling requirement, inspection regime, or certification standard that reliably separates the good from the bad.

The absence of manufacturing standards is arguably the single biggest risk factor with delta-8, more so than the molecule’s pharmacology. A clean, well-characterized sample of delta-8-THC is a reasonably well-understood psychoactive compound with decades of pharmacological data behind it. But the product you actually buy may contain residual acids from the conversion process, heavy metals leached from cheap equipment, reaction byproducts that no one has studied, synthetic terpenes that generate toxic carbonyls when heated, and a total potency that bears little relation to the number printed on the label. The molecule is not the mystery. The product is.